Alemao EA - Search Results

1

Lipid management and cholesterol goal attainment in Norway.

Ose L, Skjeldestad FE, Bakken IJ, Levorsen A, Alemao EA, Yin DD, Borgström F, Jönsson L. Ose L, et al. Among authors: alemao ea. Am J Cardiovasc Drugs. 2006;6(2):121-8. doi: 10.2165/00129784-200606020-00006. Am J Cardiovasc Drugs. 2006. PMID: 16555865 Clinical Trial.

2

Evaluation of lipid-lowering therapy and cholesterol goal attainment in Finland: the National FINRISK Study.

Alemao E, Yin D, Sintonen H, Salomaa V, Jousilahti P. Alemao E, et al. Am J Cardiovasc Drugs. 2006;6(5):349-55. doi: 10.2165/00129784-200606050-00008. Am J Cardiovasc Drugs. 2006. PMID: 17083270

3

Determinants of cholesterol goal attainment at 12 months in patients with hypercholesterolaemia not at consensus goal after 3 months of treatment with lipid-lowering drugs.

Lindgren P, Borgström F, Stålhammar J, Alemao E, Jönsson L. Lindgren P, et al. Int J Clin Pract. 2007 Aug;61(8):1410-4. doi: 10.1111/j.1742-1241.2007.01468.x. Int J Clin Pract. 2007. PMID: 17627716 Free article.

4

The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease.

Ho KT, Chin KW, Ng KS, Alemao E, Rajagopalan S, Yin D. Ho KT, et al. Am J Cardiovasc Drugs. 2006;6(6):383-91. doi: 10.2165/00129784-200606060-00005. Am J Cardiovasc Drugs. 2006. PMID: 17192128

5

Cost of care for patients treated with lipid-lowering drugs.

Carlsson A, Borgström F, Stålhammar J, Alemao E, Yin D, Jönsson L. Carlsson A, et al. Pharmacoeconomics. 2004;22 Suppl 3:25-35. doi: 10.2165/00019053-200422003-00004. Pharmacoeconomics. 2004. PMID: 15669151

6

Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study.

Van Ganse E, Laforest L, Alemao E, Davies G, Gutkin S, Yin D. Van Ganse E, et al. Curr Med Res Opin. 2005 Sep;21(9):1389-99. doi: 10.1185/030079905X59139. Curr Med Res Opin. 2005. PMID: 16197657

7

Impact of new Joint British Societies' (JBS 2) guidelines on prevention of cardiovascular disease: evaluation of serum total cholesterol goal achievement in UK clinical practice.

Rajagopalan S, Alemao E, Finch L, Yin D. Rajagopalan S, et al. Curr Med Res Opin. 2007 Aug;23(8):2027-34. doi: 10.1185/030079907X219472. Curr Med Res Opin. 2007. PMID: 17659160

8

Cholesterol goal attainment in patients with coronary heart disease and elevated coronary risk: results of the Hong Kong hospital audit study.

Lee KK, Lee VW, Chan WK, Lee BS, Chong AC, Wong JC, Yin D, Alemao E, Tomlinson B. Lee KK, et al. Value Health. 2008 Mar;11 Suppl 1:S91-8. doi: 10.1111/j.1524-4733.2008.00372.x. Value Health. 2008. PMID: 18387073 Free article.

9

Association between achieving treatment goals for lipid-lowering and cardiovascular events in real clinical practice.

Lindgren P, Borgström F, Stålhammar J, Alemao E, Yin DD, Jönsson L. Lindgren P, et al. Eur J Cardiovasc Prev Rehabil. 2005 Dec;12(6):530-4. doi: 10.1097/01.hjr.0000160724.05165.dc. Eur J Cardiovasc Prev Rehabil. 2005. PMID: 16319541

10

Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemia.

Cook JR, Yin D, Alemao E, Drummond M. Cook JR, et al. Pharmacoeconomics. 2004;22 Suppl 3:37-48. doi: 10.2165/00019053-200422003-00005. Pharmacoeconomics. 2004. PMID: 15669152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters